PrimeRFP SCOUT · Federal Contract Recompete Brief

W81XWH20C0137Further development of ETVAX a vaccine — Scandinavian Biopharma Holding Ab

Scandinavian Biopharma Holding Ab holds $21.8M across 1 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2028 PoP end — agencies typically plan 12–18 months ahead.

W4pz Usa Med Rsch Acquis Act
Awarding office
Scandinavian Biopharma Holding Ab
Recipient
Sep 30, 2028
PoP end
$32.5M
Obligated
541714
NAICS
Q517
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Scandinavian Biopharma Holding Ab — $90

Contract facts

NONE
Contract numberW81XWH20C0137
Also listed asW81XWH-20-C-0137
AgencyW4pz Usa Med Rsch Acquis Act
Awarding officeW4pz Usa Med Rsch Acquis Act
IncumbentScandinavian Biopharma Holding Ab
UEIZKASUJ7ZZC98
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCQ517
Related solicitationW81XWH20R0005
PoP end (current)Sep 30, 2028
Obligated$32.5M

FURTHER DEVELOPMENT OF ETVAX, A VACCINE AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC). is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Scandinavian Biopharma Holding Ab. Estimated value $51.7M ($32.5M obligated). Current period of performance ends Sep 30, 2028. Last award drew 1 bidder. Related solicitation W81XWH20R0005.

FURTHER DEVELOPMENT OF ETVAX, A VACCINE AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC).

Recompete timing

Public
Expiring in 754 days

Current PoP ends Sep 30, 2028 (754 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 30, 2027.

Incumbent footprint

Public record

Scandinavian Biopharma Holding Ab$21.8M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$21.8M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81XWH20C0137?

W81XWH20C0137 (Further development of ETVAX a vaccine) is a W4pz Usa Med Rsch Acquis Act award with an estimated value of $51.7M, currently held by Scandinavian Biopharma Holding Ab. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81XWH-20-C-0137?

W81XWH-20-C-0137 is the dashed form of PIID W81XWH20C0137 (Further development of ETVAX a vaccine), held by Scandinavian Biopharma Holding Ab. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81XWH20C0137?

W4pz Usa Med Rsch Acquis Act awarded W81XWH20C0137 to Scandinavian Biopharma Holding Ab.

Who is the incumbent on W81XWH20C0137?

Scandinavian Biopharma Holding Ab is the incumbent with $21.8M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2028.

When does Scandinavian Biopharma Holding Ab’s W81XWH20C0137 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W81XWH20C0137 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81XWH20C0137